Filing Details

Accession Number:
0001140361-17-019306
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-10 15:23:58
Reporting Period:
2017-04-28
Filing Date:
2017-05-10
Accepted Time:
2017-05-10 15:23:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1514980 Brian Mueller 105 Digital Drive
Novato CA 94949
Svp, Corporate Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-04-28 270 $70.30 18,350 No 5 A Direct
Common Stock Disposition 2017-05-08 4,882 $91.17 13,468 No 4 S Direct
Common Stock Acquisiton 2017-05-08 2,600 $21.51 16,068 No 4 M Direct
Common Stock Disposition 2017-05-08 2,600 $93.17 13,468 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 A Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to buy Common Stock) Disposition 2017-05-08 2,600 $0.00 2,600 $21.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,671 2010-11-12 2020-05-11 No 4 M Direct
Footnotes
  1. Represents shares acquired by the reporting person on April 28, 2017, pursuant to the issuer's Employee Stock Purchase Plan.
  2. Trade made pursuant to a 10b5-1 plan executed on March 13, 2017.
  3. All shares were sold at the same price.
  4. Option grant vests 12/48th on March 22, 2018 and 1/48th on the 22nd day of each month thereafter.